Validity of medication-based co-morbidity indices in the Australian elderly population

Australian and New Zealand Journal of Public Health

Volumn 33, Issue 2, 2009, Pages 126-130

  Vitry, Agnes ^a   Wong, Soo Ann ^a   Roughead, Elizabeth E ^a   Ramsay, Emmae ^b   Barratt, John ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Chronic disease drug therapy; Co morbidity; Drug prescriptions; Risk adjustment methods

Indexed keywords

AGED; ARTICLE; AUSTRALIA; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEALTH; HUMAN; INTERMETHOD COMPARISON; MALE; MEDICATION BASED COMORBIDITY INDEX; MEDICATION BASED DISEASE BURDEN INDEX; MORTALITY; PREDICTIVE VALIDITY; RX RISK V; SCORING SYSTEM; SELF REPORT; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

AGED; AGED, 80 AND OVER; AUSTRALIA; COMORBIDITY; DRUG UTILIZATION; HEALTH STATUS INDICATORS; HUMANS; LONGITUDINAL STUDIES; MORTALITY; PRESCRIPTION DRUGS; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; SENSITIVITY AND SPECIFICITY; VETERANS;

EID: 65349106005     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-6405.2009.00357.x     Document Type: Article

References (23)

1. Australian Institute of Health and Welfare. Chronic Diseases and Associated Risk Factors in Australia 2006. Canberra (AUST): AIHW; 2006. AIHW Catalogue No.: PHE 81.
2. Nuyen J, Schellevis FG, Satariano WA, Spreeuwenberg PM, Birkner MD, van den Bos GAM, et al. Comorbidity was associated with neurologic and psychiatric diseases: a general practice-based controlled study. J Clin Epidemiol. 2006;59(12):1274-84.
3. Hall SE A user's guide to selecting a comorbidity index for clinical research. J Clin Epidemiol. 2006;59(8):849-55.
4. De Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol. 2003;56(3):221-9.
5. Dominick KL, Dudley TK, Coffman CJ, Bosworth HB. Comparison of three comorbidity measures for predicting health service use in patients with osteoarthritis. Arthritis Rheum. 2005;53(5):666-72.
6. Wilchesky M, Tamblyn RM, Huang A. Validation of diagnostic codes within medical services claims. J Clin Epidemiol. 2004;57(2):131-41.
7. Von Korff M, Wagner EH, Saunders KA. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992;45:197-203.
8. Sloan KL, Sales AE, Liu CF, Fishman P Nichol P Suzuki NT, et al. Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument. Med Care. 2003;41(6):761-74.
9. Sales AE, Liu CF, Sloan KL, Malkin J, Fishman PA, Rosen AK, et al. Predicting costs of care using a Vharmacy-based measure risk adjustment in a veteran population. Med Care. 2003;41(6):753-60.
10. Johnson ML, EI-Serag HB, Tran TT, Hartman C, Richardson P, Abraham NS. Adapting the Rx-Risk-V for mortality prediction in outpatient populations. Med Care. 2006;44(8):793-7.
11. Fan VS, Maciejewski ML, Liu CF, McDonell MB, Fihn SD. Comparison of risk adjustment measures based on self-report, administrative data, and pharmacy records to predict clinical outcomes. Health Services & Outcomes Research Methodology. 2006;6(1-2):21-36.
12. Perkins AJ, Kroenke K, Unutzer J, Katon W, Williams JW, Hope C, et al. Common comorbidity scales were similar in their ability to predict health care costs and mortality. J Clin Epidemiol. 2004;57(10):1040-8.
13. George J, Vuong T, Bailey MJ, Kong DC, Marriott JL, Stewart K. Development and validation ofthe medication-based disease burden index. Ann Pharmacother. 2006;40(4):645-50.
14. Andrews G, Cheok F, Carr S. The Australian longitudinal study of ageing. Australian Journal on Ageing. 1989;8(2):31-5.
15. Giles LC, Glonek GF, Luszcz MA, Andrews GR. Effect of social networks on 10 year survival in very old Australians: the Australian longitudinal study of aging. J Epidemiol Community Health. 2005;59:574-9.
16. Idler EL, Benyarnini Y. Self-rated health and mortality: a review of twenty-seven community studies. J Health Soc Behav. 1997;38(1):21-37.
17. DeSalvo KB, Bloser N, Reynolds K, He J, Muntner P. Mortality prediction with a single general self-rated health question: a meta-analysis. J Gen Intern Med. 2006;21(3):267-75.
18. Powell H, Lim LL, Heller RF. Accuracy of administrative data to assess comorbidity in patients with heart disease: an Australian perspective. J Clin Epidemiol. 2001;54(7):687-93.
19. Bayliss EA, Ellis JL, Steiner JF. Subjective assessments of comorbidity correlate with quality oflife health outcomes: initial validation ofa comorbidity assessment instrument. Health Qual Life Outcomes. 2005;3:51.
20. Farley JF, Harley CR, Devine JW. A comparison of comorbidity measurements to predict healthcare expenditures. American Journal of Managed Care. 2006;12(2):110-9.
21. Murray CJ, Lopez AD. The Global Burden of Disease: A Comprehensive Assessment of Martality and Disabilily from Diseases, Inhuries and Risk Factors in 1990 and Projected to 2020. Cambridge (UK): Harvard University Press; 1996.
22. Vos T, Begg SJ. Victorian Burden of Disease Study: Mortality. Melbourne (AUST): Public Health and Development Division, Department of Human Services; 1999.
23. Schneeweiss S, Seeger JD, Maclure M, Wang PS, Avorn J, Glynn RJ. Performance ofcomorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol. 2001;154(9):854-64.